Stock DNA
Agricultural Commodities/Milling
CAD 361 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
3.75
-920.98%
188.78
Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Mar 2025)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.36%
0%
-5.36%
6 Months
3.25%
0%
3.25%
1 Year
5.65%
0%
5.65%
2 Years
3875.0%
0%
3875.0%
3 Years
-43.92%
0%
-43.92%
4 Years
-67.55%
0%
-67.55%
5 Years
5200.0%
0%
5200.0%
BioHarvest Sciences, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
104.25%
EBIT Growth (5y)
-217.30%
EBIT to Interest (avg)
-4.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
3.75
Sales to Capital Employed (avg)
0.11
Tax Ratio
0.06%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
188.78
EV to EBIT
-38.45
EV to EBITDA
-46.85
EV to Capital Employed
40.56
EV to Sales
10.66
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-105.48%
ROE (Latest)
-920.98%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Jun 2023
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 0 Foreign Institutions (0%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'25 - YoY
Mar'25
Mar'24
Change(%)
Net Sales
11.30
7.20
56.94%
Operating Profit (PBDIT) excl Other Income
-1.90
-1.60
-18.75%
Interest
0.80
7.00
-88.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.40
-8.90
61.80%
Operating Profit Margin (Excl OI)
-218.70%
-266.50%
4.78%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2025 is 56.94% vs 148.28% in Mar 2024
Consolidated Net Profit
YoY Growth in quarter ended Mar 2025 is 61.80% vs -790.00% in Mar 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
34.50
17.10
101.75%
Operating Profit (PBDIT) excl Other Income
-7.90
-12.30
35.77%
Interest
2.60
1.40
85.71%
Exceptional Items
-4.80
-1.40
-242.86%
Consolidate Net Profit
-17.70
-17.00
-4.12%
Operating Profit Margin (Excl OI)
-277.50%
-786.50%
50.90%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 101.75% vs 137.50% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -4.12% vs -16.44% in Dec 2023
About BioHarvest Sciences, Inc. 
BioHarvest Sciences, Inc.
Agricultural Commodities/Milling
BioHarvest Sciences Inc., formerly Canna-V-Cell Sciences Inc., is a Canada-based company engaged in the production and sale of a food-based nutraceutical product, VINIA. The Company’s segments include Vinia and Cannabis. Vinia segment is engaged in the development, design, manufacture and marketing of Vinia for the privet sectors. Cannabis segment is engaged in the development, design, manufacture and marketing of medical Cannabis. VINIA is manufactured by growing plant cells from red grapes in solution in Bioreactors and consists of a fine dry purple pink powder containing Piceid. The product is produced using its BioHarvest Platform Technology, which permits the growth in solution, in bioreactors, of the desired plant cells resveratrol in its natural state.






